rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Bafna Pharmaceuticals Ltd. - Research Center
532989 BAFNAPHARM Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 16 Mar ' 15 Mar ' 14 Mar ' 13 Mar ' 12
Sources of funds
Owner's fund
Equity share capital 18.66 18.66 18.66 18.66 18.38
Share application money - - - 3.13 5.87
Preference share capital - - - - -
Reserves & surplus 40.79 52.97 50.12 45.66 39.64
Loan funds
Secured loans 80.48 63.70 99.34 91.92 80.65
Unsecured loans - - - - -
Total 139.92 135.33 168.12 159.36 144.54
Uses of funds
Fixed assets
Gross block 72.44 70.14 78.31 78.83 79.38
Less : revaluation reserve - - - - -
Less : accumulated depreciation 25.44 21.51 15.37 12.43 9.56
Net block 46.99 48.63 62.93 66.40 69.82
Capital work-in-progress - - - - -
Investments 18.33 18.33 1.43 1.43 1.43
Net current assets
Current assets, loans & advances 119.61 118.30 158.23 175.11 136.11
Less : current liabilities & provisions 45.01 49.93 54.47 83.58 62.82
Total net current assets 74.60 68.37 103.76 91.53 73.29
Miscellaneous expenses not written - - - - -
Total 139.92 135.33 168.12 159.36 144.54
Notes:
Book value of unquoted investments 1.43 1.43 1.43 1.43 1.43
Market value of quoted investments - - - - -
Contingent liabilities 1.64 11.56 18.24 14.07 13.71
Number of equity sharesoutstanding (Lacs) 186.56 186.56 186.56 186.56 183.81
Close
Add Bafna Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Bafna Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close